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ABSTRACT The proximal histidine NH proton of deoxymyoglobin experiences a large hyperfine shift resulting in its 'H nuclear
magnetic resonance (NMR) signal appearing at -76 ppm (at 350C), downfield of the diamagnetic spectral region. 'H NMR of
this proton is used to monitor sarcoplasmic oxygen pressure in isolated perfused rat heart. This method monitors intracellular
oxygenation in the whole heart and does not reflect oxygenation in a limited region. The deoxymyoglobin resonance intensity
is reduced upon conversion of myoglobin to the ferric form by sodium nitrite. 'H resonances of the N8H protons of the a and
subunits of bovine deoxyhemoglobin do not interfere with the measurement of myoglobin deoxygenation in blood-perfused
rat heart. We find that steady-state myoglobin deoxygenation is increased progressively (and reversibly) as oxygenation of the
perfusing medium is decreased in both saline and red blood cell-perfused hearts at constant work output. An eightfold increase
in the heart rate of the blood-perfused heart resulted in no change in the deoxymyoglobin signal intensity. Intracellular P02 of
myoglobin-containing cells is maintained remarkably constant in changing work states.
INTRODUCTION
Myoglobin, a monomeric, oxygen-binding protein present at
high concentration (200,umol/kg wet weight) (Schuder et al.,
1979) in the sarcoplasm of heart cells, delivers oxygen to
mitochondria to form an integrated system supplying oxi-
datively generated ATP to the working heart (Wittenberg and
Wittenberg, 1989). Expression of the myoglobin gene is sub-
ject to physiological control in response to hypoxia and other
factors (Williams, 1990). Short-term controls regulate the
instantaneous rate of aerobic ATP synthesis requiring in-
creased oxygen uptake in the face of changing demand. Sev-
eral recent reports have illuminated the role of myoglobin in
maintaining intracellular oxygen supply and maximum work
output in the heart. It has been shown that in the absence of
functional myoglobin the phosphocreatine level in the heart
falls faster (Taylor et al., 1986) and that cardiac function is
diminished during hypoxia (Braunlin et al., 1986). Gayeski
and Honig (1991) have observed that in working heart, in-
tracellular myoglobin is close to half saturation with oxygen
in several species (including dogs and rats), over a wide
range of ventricular work and arterial oxygen supply. Be-
cause cardiac intracellular myoglobin is near equilibrium
with oxygen (Tamura et al., 1978; Wittenberg and Witten-
berg, 1985), these findings show that cardiac intracellular P02
is between 1 and 5 torr, depending on the value taken for the
P02 at which intracellular myoglobin is half saturated with
oxygen. Within each cell, the oxygen pressure is kept
everywhere the same (without detectable oxygen pressure
gradients) by "buffering" of free 02 by reversible binding to
myoglobin, and by myoglobin-facilitated diffusion of oxy-
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gen from regions of high oxygen pressure (e.g., capillary
wall) to regions of low oxygen pressure (e.g., mitochondria),
(Cole et al., 1982). Nuclear magnetic resonance (NMR) evi-
dence shows that myoglobin is mobile and undergoes un-
hindered rotational diffusion in the heart (Livingston et al.,
1983). Because myoglobin is maintained, partially deoxy-
genated in situ myocytes are protected from short-term fluc-
tuations in oxygen supply. The respiration of cardiac myo-
cytes does not become oxygen limited until myoglobin is
completely deoxygenated (Wittenberg and Wittenberg,
1985) and myoglobin deoxygenation in the saline-perfused
heart precedes the loss of intracellular energy reserves
(Kreutzer and Jue, 1991).
NMR spectroscopy provides a noninvasive and specific
technique to measure metabolites in cells and tissues. Be-
cause NMR is a nondestructive technique, time courses of
different events can be followed in the same preparation,
enabling one to study the same heart under a variety of per-
fusion and work states. The method permits real-time con-
tinuous monitoring, and evaluation of reversibility. 31P NMR
has been applied extensively to study intracellular high-
energy phosphate levels, intracellular free Mg2+, and intra-
cellular pH of heart (Radda, 1986). High-energy phosphate
signals reflect cellular bioenergetics and serve as an indirect
measurement of intracellular oxygenation. However, under
certain conditions, such as during moderate hypoxia, the 31P
NMR signals may not be sufficiently sensitive to accurately
report on changes in oxygen delivery/utilization. Recently
Jue and co-workers (Kreutzer and Jue, 1991; Kreutzer et al.,
1992) have demonstrated that 1H NMR is a very sensitive
direct marker of myoglobin oxygenation in perfused heart.
The 1H NMR method monitors oxygenation in the entire
volume of the whole heart rather than reporting oxygenation
at the surface of the heart or in a limited region of the left
ventricle as do optical techniques. The 1H NMR method
monitors the exchangeable proximal histidine imidazole pro-
ton of deoxymyoglobin. This is a uniquely resolvable proton
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in the NMR spectrum, which experiences a large hyperfine
shift (to -79 ppm at 25°C) and rapid relaxation (Livingston
et al., 1983). This resonance disappears upon oxygenation of
myoglobin in solution, consistent with a shift of the heme
iron from the paramagnetic electronic state in deoxymyo-
globin to the diamagnetic electronic state in oxymyoglobin
(Livingston et al., 1983). The resonance has been shown to
be sensitive to temperature but does not exhibit any pH-
dependent shift between pH 6 and 7 (La Mar et al., 1978).
Cellular P02 reflects the balance between 02 uptake and
delivery, and delivery depends on capacity, oxygenation, and
flow rate of the perfusion medium. To validate the method
we have designed our study to examine myoglobin deoxy-
genation under a variety of oxygenation levels and flow rates
as well as during perfusion with blood, which has a higher
02 capacity than saline-based media. Kreutzer and Jue (1991)
have previously observed the deoxymyoglobin resonance in
isolated saline-perfused well-oxygenated hearts at flow rates
below 2 ml/min. In our study, using the 1H NMR method we
have found that myoglobin is partially deoxygenated in red
blood cell-perfused rat heart studied at flow rates of 0.3-4
ml/min even at low heart rates. The effects of sodium nitrite
(which inactivates myoglobin), decreased oxygen pressure,
and no-flow ischemia on the oxygenation of cardiac cells
perfused with minimal essential medium (MEM) or red
blood cell-perfused hearts were investigated. Finally we de-
termined the effect of an eightfold-increased electrical pac-
ing on the maintenance of intracellular oxygen pressure of
the heart.
MATERIALS AND METHODS
Heart preparation and perfusion
Adult male Wistar rats (400-500 g, obtained from Charles River Labora-
tories, Wilmington, MA) were heparinized and decapitated in accordance
with institutional guidelines. The hearts were isolated and perfused in the
Langendorffmode at 350C at constant pressure (90 cm H20) with a modified
HEPES-buffered MEM containing 117 mM NaCl, 5.7 mM KCI, 9.0 mM
NaHCO3, 1.5 mM NaH2PO4, 1.7 mM MgCl2, 21.1 mM HEPES, 10.8 mM
glucose, 10 mM taurine, 2 mM glutamine, 2 mM CaCl2, and 4 mM beta-
hydroxybutyrate; pH was adjusted to 7.2 with NaOH. The solution was 285
milliosmolar and was gassed with 95% 02 and 5% CO2. The perfusion
apparatus consisted of two water-jacketed Langendorff vessels connected
via a Y joint to a water-jacketed "umbilical cord" delivering perfusion me-
dium to the heart. In some experiments, after initial perfusion with MEM,
we began red-cell perfusion. Bovine blood (containing citrate) was obtained
from Max Insel Cohen (Livingston, NJ). One liter of the blood was cen-
trifuged for 5 min at 3500 rpm, after which the buffy coat was removed. The
blood was then rinsed twice with 500 ml MEM (centrifuged for 10 min at
1300 rpm) and was then stored at 4°C until used for the experiment. Bovine
serum albumin (1%), heparin (40 units/ml), and 20 ,uM adenosine (in all
experiments except one heart-perfused at a flow rate of 0.3 ml/min) were
added at the time of the NMR experiments. The perfusing blood in the
second Langendorff reservoir was passed through an inline filter to remove
particulates and then through a hollow fiber cellulose acetate dialysis unit
(Baxter Healthcare Corporation, Deerfield, IL). The gas-equilibrated MEM
solution from the first reservoir was then used as a dialyzing fluid to ex-
change gas with the blood in the dialyzer. The temperature of the bath
supplying circulating water to the water-jacketed perfusion apparatus was
adjusted such that the temperature of perfusate at the cannula was 35°C.
Humidified gas was delivered directly to the MEM. The content of oxygen,
nitrogen, and CO2 delivered to the medium was regulated by a mass flow
controller (Tylan, Torrence, CA).
A small latex balloon (size 4, obtained from Hugo Sachs Elektronik,
March-Hugstetten, Germany) attached to a fluid-filled line (saline) and con-
nected to a Gould P231D pressure transducer and Gould 2200S recorder
(Gould Electronics, Valley View, OH) was introduced into the left ventricle
for isovolumic perfusion. Left ventricular pressure was increased by in-
crementing the balloon volume using a calibrated Gilmont syringe (Gilmont
Instruments, Barrington, IL). The balloon volume was adjusted to give
an end diastolic pressure of -10 mm Hg. Constant flow experiments
with MEM were performed using a peristaltic pump in the inflow line.
Ischemia was induced by stopping the medium flow. Cardiac pacing in
the NMR magnet was accomplished with agar electrodes as described by
Burstein and Fossel (1987). Silver pacing leads were attached to 6-inch-long
agar electrodes connected to shielded wires leading to a Grass S44 physi-
ological stimulator. Heart rate and flow rate were monitored during the
experiments.
NMR spectroscopy
'H spectra were acquired using a GE Omega/Bruker 400WB spectrometer
equipped with a 20-mm 'H/'9probe with a Helmholtz-typeNMR observation
coil. Hearts, after attachment to the cannula and umbilical cord, were placed
in 20-mm (outer diameter) air-filled sample tubes (perfusate was removed
from the bottom of the NMR tube by an outflow line attached to a peristaltic
pump). The spectrometer was not field-frequency locked, and the magnetic
field was homogenized using the 'H signal of H2O (typical linewidth was
50 Hz). Typically each spectrum resulted from signal averaging 15,000
transients acquired using the 1331 solvent suppression pulse sequence
(Hore, 1983) to suppress the H20 resonance. In some experiments 50,000
transients acquired with shorter recycle time were signal averaged to achieve
better signal-to-noise ratio. The pulse sequence was tailored to give maxi-
mum excitation at 76 ppm. The sequence recycle time was -0.04 s (each
spectrum required -10 min of data acquisition). The 900 pulse width was
typically 40 ps. The spectral width was 100,000 Hz, and 2048 data points
were used. The 'H resonances were referenced to the water peak. Data were
processed with the standard Omega software (G. E., Fremont, CA) using a
200-Hz line broadening function and polynomial baseline correction. The
baseline points were selected using the ischemic spectrum of each heart; the
same points were then used for correction of all earlier spectra from that
heart. The % oxygenation of myoglobin was determined by comparing the
areas of the 'H resonance under various conditions with that acquired under
no-flow ischemia as described by Kreutzer and Jue (1991).
31p spectra were acquired with a 20mm broad-band probe. Typically each
31P NMR spectrum resulted from signal averaging 200 transients acquired
with a 450 radio frequency pulse (16 ps) and a 2.0 s sequence recycle time
(each spectrum required -6 min of data acquisition). The spectral width was
set at 10,000 Hz. Data were processed using the standard Omega software.
Time domain data were multiplied with a 50-Hz linebroadening function to
improve the signal-to-noise ratio.
In some experiments we used a perfusion medium containing no inor-
ganic phosphate (P.) to accurately measure intracellular pH under a variety
of conditions. The chemical shift of the 31P resonance of P; was then used
to measure intracellular pH (pH-) from the following equation (Gupta and
Wittenberg, 1991):
pH = 6.73 + log(a,,,, - 2.90)/(5.70 -ca0,b) (1)
where a,b, is the chemical shift difference between the Pi and phospho-
creatine resonances in ppm.
Statistical analysis was performed where possible. Data are reported as
mean ± SE. The null hypothesis was tested using a paired Student's t-test
for analysis of data obtained with one heart, and unpaired Student's t-test
for comparison of data from different hearts. Data are considered signifi-




The spectrum of a solution of purified myoglobin, deoxy-
genated in theNMR tube at 35°C, exhibited a peak at 76 ppm
assigned as the proximal histidine exchangeable N,8H (data
not shown). This resonance was not observed when oxy-
myoglobin or nitrite-treated metmyoglobin solutions were
used. Subsequent to their 'H NMR studies on deoxymyo-
globin in perfused hearts (Kreutzer and Jue, 1991), Kreutzer
et al. (1992) reported the observation of the 'H NMR signal
of a valine methyl group of oxymyoglobin as a marker of
myoglobin oxygenation in myocardium. Under our experi-
mental conditions we have been unable to use this resonance
to monitor myoglobin oxygenation accurately. We did ob-
serve this resonance in a sample containing 2.7 mM oxy-
myoglobin; however, the oxymyoglobin concentration in the
heart is -200 p,M, and the amount of time required for signal
averaging was prohibitively long. Because of the sensitivity
and reasonable time for acquisition of data obtained moni-
toring the deoxymyoglobin histidine resonance we have per-
formed all of our experiments monitoring the deoxymyo-
globin signal.
Fig. 1 shows that, as expected (Kreutzer and Jue, 1991),
the magnitude of the deoxymyoglobin resonance increased
progressively as the oxygen content of the gas mixture was
decreased from 95% to 20% and was finally switched to zero
oxygen, 95% nitrogen. The % deoxymoglobin was indistin-
guishable from 0 during perfusion with 95% 02,5% CO2
equilibrated MEM (n = 5) (representative spectra are shown
in Figs. 1 and 3) and increased significantly to 33.5 ± 5.3%
(p < 0.003, n = 4 hearts) when the oxygen pressure of
the perfusion medium was decreased by equilibration with
15-20% 02 5% CO2. Stopping the flow entirely gave rise to
a downfield-shifted ischemic signal. The magnitude of this
shift is consistent with a drop in temperature of up to 10°C,
which is within the expectations with this perfusion system,
given that the heart was not bathed in warmed medium. The
signal shifted upfield when the flow ofwarmed medium was
restarted with 95% nitrogen and sodium nitrite. We have
previously shown by absorption spectroscopy that 1-2 mM
sodium nitrite converts intracellular myoglobin to the inac-
tive high-spin ferric form (Doeller and Wittenberg, 1991)
and that the effects can be reversed by removal of nitrite
(Gupta and Wittenberg, 1991). During perfusion in the pres-
ence of nitrite, the deoxymyoglobin signal, which is normally
large in the presence of zero oxygen, 95% nitrogen, began
to disappear because of slow anaerobic conversion of intra-
cellular myoglobin to the ferric and ferric nitrite forms. There
was very little evidence of a signal in the final spectrum (Fig.
1, upper trace), indicating that the conversion of deoxymyo-
globin was virtually complete after 90 min. Fig. 2 shows the
spectra of a sample of high-spin ferric myoglobin (1 mM)
before (Fig 2, top trace) and after (Fig. 2, bottom trace) an
addition of excess nitrite. The middle trace shows a wider
region of the spectrum (shown in Fig. 1 e) of the perfused
heart obtained after 30 min of nitrite perfusion. The low
intensity of the hyperfine shifted resonances between 65 and
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FIGURE 1 1H NMR spectra of an MEM-perfused rat heart showing the
effect of oxygenation, ischemia, and conversion of myoglobin to ferric myo-
globin and ferric myoglobin nitrite (using sodium nitrite) on intracellular
deoxymyoglobin. The magnitude of the single spectral peak in each record
is proportional to the concentration of deoxymyoglobin in the heart. The %
intracellular myoglobin in the deoxy form is vanishingly small during per-
fusion with medium equilibrated with 95% oxygen (trace a) and increases
to 30% (trace b) and 70% (trace c) when the oxygen content of perfusion
medium is progressively reduced to 20% and 0%. The ischemia spectrum
(trace d) shows 100% deoxymyoglobin. After reinitiation of perfusion for
30 min with medium equilibrated with 95% nitrogen and containing 1 mM
sodium nitrite, the magnitude of the deoxymyoglobin peak drops markedly
(trace e; only 30% of intracellular myoglobin is in the deoxy form) and there
is an increase in ferric myoglobin and/or ferric myoglobin nitrite resonances
as shown in Fig. 2. After 90 min of anaerobic nitrite perfusion, the deoxy-
myoglobin peak had become vanishingly small (c 10%, tracef) indicating
complete conversion of intracellular deoxymyoglobin to the ferric and ferric
nitrite forms. Intracellular oxygen can no longer be monitored, because the
endogenous probe has been inactivated. In this experiment and those shown
in Figs. 2 and 3, pyruvate replaced (3-OH butyrate as substrate, and aden-
osine and heparin were omitted from the medium.
95 ppm in the lower trace strongly suggests that ferric myo-
globin is not the sole product. This suggests that ferric nitrite
myoglobin may also be present (Bondoc and Timkovich,
1989). Presumably deoxymyoglobin is not converted to the
oxy form, because no oxygen is present. The deoxymyo-
globin N ;H resonance appears in a region of the spectrum
where there are no resonances observed for either ferric or
ferric nitrite myoglobin (see Fig. 2, dashed line). The spectral
features of high-spin ferric myoglobin shown in this figure
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FIGURE 2 Comparison of IH NMR spectra of the MEM-perfused rat
heart anaerobically perfused with sodium nitrite for 30 min with spectra of
solutions of 1 mM high-spin ferric myoglobin and of 1 mM ferric myoglobin
nitrite. Middle spectrum shows the spectrum of Fig. 1 e with expanded scale.
30% of the intracellular myoglobin is still in the deoxy form with its reso-
nance at 76 ppm (- - - - - -). The rest of the intracellular myoglobin is
converted to ferric myoglobin or its nitrite derivative, as indicated by the
additional resonances near 50, 68, 81, and 87 ppm. Note that the deoxy-
myoglobin peak appears in a region where the spectra of both ferric myo-
globin and ferric nitrite myoglobin are clear of spectral features. Horse
met-myoglobin (1.0 mM, Sigma Chemical Co.) dissolved in 0.05 M Na-
Hepes, pH 7.4 containing 0.5 mM EDTA was used to measure the top
spectrum of high-spin ferric myoglobin. Sodium nitrite in large excess (200
mM) was added to this sample to convert ferric myoglobin to the nitrite
derivative whose NMR spectrum is shown in the bottom trace.
are very similar to the spectrum of met-myoglobin reported
by Bondoc and Timkovich (1989); however, the spectrum of
the nitrite-treated sample is somewhat different, probably
because of differing pH conditions. Nitrimyoglobin was pre-
pared at pH 5.5 in the experiments reported by Bondoc and
Timkovich (1989) while our solutions were maintained at pH
7.4.
Fig. 3 shows that deoxygenation of myoglobin in the
MEM-perfused heart increased reversibly with increased
beating of the heart in the presence of ,3 agonists. Here the
initial spectrum (Fig. 3, trace a), in which the medium was
equilibrated with 95% 02, 5% C02, again showed no de-
oxymyoglobin signal. When the oxygen content of the gas
mixture was reduced to 15% 02 while maintaining 5% C02,
31% deoxymyoglobin was observed (Fig. 3, trace b). The
addition of 50 nM norepinephrine, an inotropic agent, while
maintaining the same flow rate and perfusate oxygenation,
caused the heart rate to increase from 185 to 400 beats per
min (bpm). The deoxymyoglobin level visibly increased, as
expected, given that the increased work required a higher rate
of oxygen uptake to meet the demand for more ATP pro-
duced by oxidative phosphorylation (Fig. 3, trace c). One h
95%02, 5%002 - -
k,vA z/v La.
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FIGURE 3 'H NMR spectra of an isovolumic MEM-perfused rat heart
showing the reversible effect of perfusate deoxygenation and heart beat
stimulation on the deoxygenation of intracellular myoglobin. Trace a shows
the fully oxygenated control; myoglobin deoxygenation was vanishingly
small, and heart rate was 400 bpm. Trace b shows that decreasing oxy-
genation of the perfusion medium to 15% oxygen from 95% decreased
intracellular P02 and increased deoxymyoglobin to 31%. The heart rate was
185 bpm. The addition of 50 nM norepinephrine (NE) increased the heart
rate from 185 to 400 bpm, which would be expected to increase the oxygen
consumption of the heart. Trace c shows that the deoxymyoglobin resonance
increased to 77% with norephinephrine indicating that the intracellular P02
decreased, (to 1 torr from 6 torr). One h later, the heart rate dropped again
to 185 bpm, and deoxymyoglobin decreased to 20% (trace d, P02 = 10 toff)
comparable to that observed before norepinephrine treatment at this level
of medium oxygenation 2 h earlier (trace b). Increasing medium oxygen-
ation to 95% oxygen again lowered the deoxymyoglobin resonance to neg-
ligible levels, even though heart rate had dropped to 130 bpm (trace e). The
final no-flow ischemia spectrum is shown in trace f.
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FIGURE 4 31PNMR spectra ofthe isovolumic blood-perfused heart. Data
were acquired using the parameters described in Materials and Methods with
the same heart whose 'H NMR spectra are shown in Fig. 6. The initial
spectrum (a) was acquired during control conditions before the acquisition
of 'H NMR spectra. The final "P spectrum (b) was acquired during no-flow
ischemia just after acquisition of the final 'H spectrum. The inorganic phos-
phate (Pi), phosphocreatine (PCr), and ATP (,BATP) resonances are labeled.
later the heart rate dropped to 185 bpm, and 20% deoxy-
myoglobin was observed, demonstrating that the effects of
pacing were reversible (Fig. 3, trace d). When the oxygen
content of the gas mixture was increased to 95% the deoxy-
myoglobin resonance intensity was negligible (Fig. 3, trace
e). Finally the flow was stopped, the heart rate dropped to 0,
and myoglobin deoxygenation increased after the first 10 min
of ischemia and reached maximal intensity in the subsequent
10 min (Fig. 3, trace f). At this point the resonance was
considerably downfield shifted because of the expected tem-
perature drop.
We also performed a series of studies with the blood-
perfused heart, using washed beef red blood cells at -45%
hematocrit. A typical 31P NMR spectrum of a well-
oxygenated blood-perfused heart is shown in Fig. 4 a (upper
spectrum). This spectrum validates the integrity of the blood-
perfused beating heart model, because it shows physiological
low Pi levels, high phosphocreatine, and ATP levels with pHi
of 6.9. The ischemic heart at the end of a 'HNMR experiment
(Fig. 4 b, lower spectrum) showed negligible phosphocrea-
tine and ATP peaks and high Pi, and the pHi had dropped to
6.2. Thus "P NMR is a sensitive assay of compromised en-
ergy reserves, although it is not as sensitive to more subtle
changes in oxygenation, such as mild to moderate hypoxia
(Kreutzer and Jue, 1991).
In well-perfused hearts we have found that any 'H reso-
nance intensity due to deoxyhemoglobin is negligible and
does not interfere with the calculation of% deoxymyoglobin.
This is not the case in poorly perfused hearts exhibiting par-
tial ischemia with visible pooling of blood in the blood ves-
sels. Under these conditions resonances assigned to the ,3 and
a subunits of deoxyhemoglobin (La Mar et al., 1980;
Kreutzer et al., 1993) appear in the 'H NMR spectrum at
about 74 ppm and 62 ppm, respectively, upfield of the de-
oxymyoglobin signal (see Fig. 5). Thus, inadequate perfu-
sion is readily detected. Further experiments were not per-
formed on hearts that exhibited deoxyhemoglobin
resonances.
Blood has an increased oxygen capacity compared with
MEM, and the oxygen affinity of beef red blood cells is
similar to that of human red blood cells (Fronticelli and
Bucci, 1994). We have measured the P50 of the bovine blood
used in these studies and find it is 25 torr at 37°C. Fig. 6
shows that the deoxymyoglobin signal in the blood-perfused
heart is also well resolved and responds to changes in oxy-
genation of the perfusing blood. Decreasing the oxygenation
of the blood while maintaining heart rate resulted in in-
creased myoglobin deoxygenation. The spectra shown are
90 85 80 75 70 65 60 55
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FIGURE 5 'H NMR spectrum of a blood-perfused rat heart showing the
presence of deoxyhemoglobin resonances resulting from a flawed perfusion.
The resonances at -74 and 62 ppm represent deoxyhemoglobin signals from
blood that has pooled in the myocardium. By comparison with the proton
NMR spectrum of deoxyhemoglobin (La Mar et al., 1980) we attribute the
resonance at 74 ppm to the 1B chains and that at 62 ppm to the a chains of
hemoglobin. The ischemic deoxymyoglobin peak at 76 ppm overlaps with
the (3 chain deoxyhemoglobin peak.
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FIGURE 6 'H NMR spectra of an isovolumic blood-perfused rat heart
showing the effect of changing perfusate oxygenation on the deoxymyo-
globin resonance. Percent deoxymyoglobin, measured from the area under
the peak, was 30% with 95% 02 (trace a; heart rate = 138 bpm), 38% with
medium equilibrated with 20% 02 (trace b; heart rate = 132 bpm), and 60%
with 10% 02 (trace c; heart rate = 126 bpm). Although the heart rate
remained relatively constant, myoglobin deoxygenation increased slightly
when the blood was equilibrated with 20% oxygen. Decreasing the medium
oxygen pressure to 10% oxygen significantly increased myoglobin deoxy-
genation indicating a drop of intracellular oxygen pressure from 5 to 2 torr.
Trace d shows the final ischemic spectrum with 100% of the intracellular
myoglobin in the deoxy form.
from one representative heart. In a series of experiments the
percent myoglobin deoxygenation was 24.4 ± 2.1% (n = 5)
with 95% oxygen equilibration, and 30.0 ± 1.5% (n = 9)
with 20% oxygen equilibration of the perfusing blood. These
values are significantly different (p s 0.01) and demonstrate
the precision of the 1H NMR method in measuring differ-
ences of a small magnitude within the same heart and be-
tween different hearts. Decreasing blood oxygenation by
equilibration with 10% 02, 5% CO2 significantly increased
the reduction of intracellular myoglobin to 55.5 ± 4.5% of
total n = 2. This value is significantly different from that
observed with 95% oxygen equilibration (p ' 0.005) or 20%
oxygen equilibration (p ' 0.0001).
Fig. 7 shows representative spectra of a blood-perfused
heart during electrical pacing. In this heart, as in others, there
was no significant change in myoglobin deoxygenation when
pacing was varied progressively from 60 to 252 bpm, at a
given flow rate. Furthermore, we observed no correlation
between myoglobin deoxygenation and heart rate
R' = 0.00058 (see Fig. 8) when heart rate was varied from
60 to 480 bpm (n = 26). This suggests that the flux of oxygen
from the red blood cells to the mitochondria keeps pace with
the rate of oxygen uptake so that the steady-state level of
myoglobin deoxygenation is not changed during pacing. In
contrast, twofold stimulation of the heart rate (by norepi-
nephrine) in saline-perfused hearts resulted in reversibly in-
creased myoglobin deoxygenation. The saline perfusate has
a much lower oxygen capacity, which may account for the
greater response of tissue oxygenation to increased stimu-
lation.
We use intracellular myoglobin deoxygenation as an en-
dogenous probe of intracellular oxygen pressure. The Hill
equation with n = 1 describes the equilibrium between oxy-
gen and myoglobin:
Y/1-Y= kPo2
where Y is the fractional saturation of myoglobin with oxy-
gen, k is a constant for the system, and P02 is the partial
ppm
FIGURE 7 The effect of increased electrical pacing on the 'HNMR spec-
tra of an isovolumic blood-perfused rat heart. In this representative experi-
ment, the myoglobin was 27%, 28%, and 22% deoxygenated as pacing was
increased fourfold from 60 bpm (trace a), to 132 bpm (trace b), to 252 bpm
(trace c), respectively. Accordingly, there was no significant difference in
intracellular oxygen pressure (average 7 torr) during a fourfold increase in
pacing. The final spectrum of no-flow ischemia is shown in trace d.
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FIGURE 8 Scattergram showing the effect of increasing heart rate on
deoxymyoglobin level in blood perfused hearts. There is no correlation
between heart rate, over an eightfold range, and % myoglobin deoxygen-
ation. The correlation coefficient R2 = 0.00058 (n = 25 observations, six
hearts).
pressure of oxygen in the intracellular myoglobin-containing
compartment. The P50 for rat heart myoglobin in isolated
heart cells is 2.3 torr at 37°C, and 1.3 torr at 30°C (Wittenberg
and Wittenberg, 1985). Here, we use a value of P50 = 2.5 torr.
The average value of myoglobin deoxygenation in blood-
perfused paced rat heart is 23.9 ± 1.2% (n = 26) with a range
of values from a low of 13% to a high of 35%. Therefore Y,
the average fractional saturation of myoglobin with oxygen
is 1.00 - 0.24 = 0.76, and the calculated intracellular P02 of
the beating blood- perfused heart has an average value of 8
torr with a range from 4.6 to 16.7 torr under our conditions.
At this intracellular P02 myoglobin functions in facilitated
diffusion, and the measurement of myoglobin oxygenation is
exquisitely sensitive to changes in P02.
Although there was no correlation (R2 = 0.063) between
flow rate (0.3 - 4.0 ml/min) and % deoxymyoglobin (Fig. 9)
there was a trend toward higher % deoxymyoglobin at the
lower flow rates, and it is possible that less deoxymyoglobin
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FIGURE 9 Scattergram showing the effect of increasing flow rate on
deoxymyoglobin level in blood-perfused hearts. There is no correlation be-
tween flow rate, from 0.3 to 4.0 ml/min, and % myoglobin deoxygenation.
The correlation coefficient R2 = 0.063 (n = 24 observations, six hearts).
similar (low) flow rates (1 ml/min) and low heart rate (60
bpm), there was no difference in myoglobin deoxygenation
of a blood-perfused heart (30%) compared with that of an
MEM-perfused heart (27%). Under these conditions the ca-
pacity of MEM is sufficient to deliver oxygen by simple
diffusion at a rate high enough to meet the low oxygen de-
mand. We did observe a flow rate dependence of myoglobin
deoxygenation in saline-perfused hearts similar to that re-
ported by Kreutzer and Jue (1991). At flow rates greater than
3.0 ml/min the deoxymyoglobin resonance was not observed
in saline-perfused hearts (data not shown). Our finding that
myoglobin is partially deoxygenated in the blood-perfused
rat heart is in agreement with the results of Gayeski and
Honig (1991) showing that myoglobin is close to half satu-
ration with oxygen in working blood-perfused hearts in situ
even at low work loads.
SUMMARY AND CONCLUSIONS
We show that noninvasive NMR spectroscopy can be used
to measure intracellular myoglobin deoxygenation and
thereby sensitively probe oxygenation of the sarcoplasm in
the beating heart. Cellular oxygenation was reversibly de-
creased during hypoxic perfusion conditions, demonstrating
that the measurement sensitively reflects changing oxygen
levels in the cells. Perfusion with nitrogen-equilibrated me-
dium resulted in a large increase in myoglobin deoxygen-
ation, and subsequent addition of sodium nitrite resulted in
the disappearance of the deoxymyoglobin signal as expected
upon conversion of myoglobin to ferric and ferric nitrite
myoglobin.
We demonstrate that 'H NMR can be used to probe oxy-
genation of the sarcoplasm in the beating blood-perfused
heart without interference from deoxyhemoglobin reso-
nances. With this technique, we have shown that myoglobin
is partially deoxygenated in the blood-perfused beating rat
heart. Furthermore we show that myoglobin deoxygenation
does not change when heart rate is varied over a range from
60 to 480 bpm. This is in agreement with the findings of
Gayeski and Honig (1991) using a completely different acute
freeze-clamping technique. The data suggest that the intra-
cellular P02 of myoglobin-containing blood-perfused cells is
maintained remarkably constant.
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